Without insurance, Ozempic’s list price is roughly $935 to $998 per month, but almost no one pays that. Through Novo Nordisk’s own NovoCare Pharmacy self-pay program, uninsured patients can get Ozempic for $349 a month (0.25 mg to 1 mg doses) or $499 a month (2 mg dose), with a $199 introductory price for new patients on their first two fills. Commercially insured patients who qualify for the manufacturer’s savings card can pay as little as $25 a month. Medicare and Medicaid beneficiaries are excluded from that specific savings card by federal law, but have separate options covered below.
Ozempic (semaglutide) is one of the most prescribed and most expensive medications in the country, and the gap between its list price and what patients actually pay is unusually wide, even by prescription drug standards. Getting this one right matters, since the difference between the wrong payment path and the right one can be hundreds of dollars a month. This guide walks through every legitimate pricing tier for 2026, in order from most to least expensive, along with the trade-offs and eligibility rules for each.
Ozempic’s List Price vs. What People Actually Pay
Ozempic’s wholesale acquisition cost, the list price before any discount or program is applied, runs approximately $935 to $998 per month depending on dose and pharmacy reporting. This is the number an uninsured patient would be billed at a standard retail pharmacy with no coupon, savings card, or manufacturer program applied. It is very rarely the number anyone actually pays, since Novo Nordisk offers direct self-pay pricing well below list, and insured patients typically pay a copay rather than the full retail rate.
The NovoCare Pharmacy Self-Pay Program
Novo Nordisk operates its own NovoCare Pharmacy self-pay program specifically for patients paying cash, whether they’re uninsured or choosing not to run the prescription through insurance. As of 2026, new patients pay $199 for each of their first two monthly fills of the 0.25 mg or 0.5 mg starter doses. After that introductory period, standard self-pay pricing is $349 per month for the 0.25 mg, 0.5 mg, or 1 mg doses, and $499 per month for the 2 mg dose.
This program is open to anyone regardless of insurance status, including patients whose insurance doesn’t cover Ozempic or who are choosing to pay cash for another reason. There’s no income requirement and no prior authorization needed, since it bypasses insurance billing entirely.
The Ozempic Savings Card, and Why It Doesn’t Help Everyone
Novo Nordisk’s separate Ozempic Savings Card can reduce the cost to as little as $25 per month, but it’s restricted to patients with commercial insurance that already covers Ozempic under their plan. This program functions as a copay card, meaning it supplements an existing insurance claim rather than replacing it, and the savings apply on top of whatever your insurance already covers.
By federal law, patients enrolled in Medicare, Medicaid, TRICARE, or other government health programs cannot use manufacturer copay cards like this one, regardless of income or need. This is a standard federal anti-kickback restriction that applies to essentially all manufacturer copay programs, not something specific to Novo Nordisk. If you’re on Medicare or Medicaid, the NovoCare self-pay program and the options below are your realistic paths, not the savings card.
Ozempic and Medicare in 2026
Ozempic is included in the first round of drugs subject to Medicare drug price negotiation under the Inflation Reduction Act, and negotiated pricing is being phased in. Medicare Part D enrollees taking Ozempic for its FDA-approved use, type 2 diabetes, are generally paying substantially less than the cash list price as these negotiated rates take effect, though the exact copay depends on your specific plan’s formulary tier and where you are in the plan year.
Ozempic is not FDA-approved for weight loss on its own; Wegovy, which contains the same active ingredient at different doses, holds that specific approval. This distinction matters for coverage, since insurance plans, including Medicare, are far more likely to cover a GLP-1 medication when it’s prescribed for its approved indication than for an off-label use.
Is Compounded Semaglutide a Cheaper Option?
Compounded semaglutide, sold through some online clinics and med spas, is often advertised at $150 to $400 per month, meaningfully less than any of the branded options above. It’s important to understand what that price difference actually represents. Compounded semaglutide is not FDA-approved, meaning it hasn’t gone through the agency’s review process for safety, purity, and consistent dosing the way Ozempic has.
With semaglutide no longer on the FDA’s drug shortage list, the legal basis that previously allowed broad compounding of this medication has narrowed significantly. The FDA has documented dosing inconsistencies and adverse events tied to compounded versions, including products using different salt forms of semaglutide that are not the same active ingredient as the FDA-approved drug. Any decision here should involve a direct conversation with your prescriber about the trade-offs, not just a price comparison.
Other Ways to Reduce What You Pay
Patient Assistance Programs
Novo Nordisk’s patient assistance program can provide Ozempic at no cost to eligible patients who are uninsured or underinsured and meet income requirements, generally set relative to the federal poverty level. This is worth applying for directly if the self-pay and savings card options are still out of reach financially, since it’s a separate program with its own application process.
Ask About a 90-Day Supply
If your insurance covers Ozempic, ask your prescriber and pharmacist whether a 90-day supply is available, since some plans price a three-month fill more favorably than three separate monthly fills. How to afford prescriptions without insurance covers this and related strategies in more depth for medications generally.
Compare Cash Prices Across Pharmacies
Standard retail cash prices for Ozempic, without a manufacturer program applied, typically run $800 to $1,100 depending on the pharmacy, which is meaningfully higher than the NovoCare self-pay rate but can still vary enough between locations to be worth a quick comparison call. Why prescription drug prices are so high in the first place explains some of the underlying structural reasons a single drug’s price varies this much by pharmacy and payer.
A Discount Card Won’t Beat NovoCare, But Check Anyway
For a drug priced in the hundreds of dollars per month like Ozempic, a standard NuLifeSpan Rx prescription discount card is unlikely to beat Novo Nordisk’s own self-pay program, since manufacturer-direct pricing is specifically designed to undercut general retail cash pricing for this drug. Where a discount card can still help is on the many other prescriptions in a household, so it’s worth keeping one on hand and asking the pharmacist to check it against any other medication you’re filling on the same visit.
Quick Reference: Every Ozempic Pricing Path in 2026
| Payment Path | Approximate Monthly Cost | Who Qualifies |
| List price / standard retail cash | $935–$1,100 | Anyone; this is the default if no program is applied |
| NovoCare self-pay, new patient intro | $199 (first two fills, 0.25/0.5 mg) | Uninsured or self-pay patients new to the offer |
| NovoCare self-pay, standard | $349 (0.25–1 mg) / $499 (2 mg) | Any self-pay patient, insured or not |
| Ozempic Savings Card | As low as $25 | Commercially insured patients with Ozempic coverage; excludes Medicare/Medicaid/TRICARE |
| Medicare Part D | Varies by plan; negotiated pricing phasing in | Medicare enrollees with Ozempic on their plan formulary |
| Patient assistance program | $0 for eligible patients | Uninsured/underinsured patients meeting income requirements |
Frequently Asked Questions
What is the cheapest legitimate way to get Ozempic without insurance?
For most uninsured patients, Novo Nordisk’s own NovoCare Pharmacy self-pay program is the lowest reliable price: $199 per month for new patients on their first two fills of the starter doses, then $349 or $499 per month depending on dose. This is typically far below standard retail cash pricing at a regular pharmacy.
Can Medicare or Medicaid patients use the Ozempic Savings Card?
No. Federal law prohibits patients enrolled in Medicare, Medicaid, TRICARE, or other government health programs from using manufacturer copay cards like the Ozempic Savings Card, regardless of income or financial need. Medicare enrollees should instead look at their plan’s specific Part D coverage and copay for Ozempic, and ask about patient assistance programs if the cost is still unaffordable.
Is compounded semaglutide a safe alternative to Ozempic?
Compounded semaglutide is not FDA-approved, and the FDA has documented dosing inconsistencies and adverse events associated with some compounded products, including versions using semaglutide salt forms that differ from the active ingredient in FDA-approved Ozempic. With semaglutide no longer on the FDA shortage list, the legal basis for broad compounding has also narrowed. This is a decision to discuss directly with your prescriber rather than deciding on price alone.
Does a prescription discount card work on Ozempic?
You can present a discount card for Ozempic, but for a high-cost brand-name drug like this one, it’s unlikely to beat the manufacturer’s own self-pay program. Discount cards tend to provide their biggest advantage on generic medications and lower-cost brand drugs rather than expensive specialty and GLP-1 medications, where manufacturer-direct pricing is usually the better deal.
Why is Ozempic covered differently than Wegovy by insurance?
Ozempic is FDA-approved for type 2 diabetes and related cardiovascular and kidney risk reduction, while Wegovy, the same active ingredient at different doses, is FDA-approved specifically for chronic weight management. Insurance plans, including Medicare, generally only cover a medication for its FDA-approved indication, which is why coverage and copay amounts can differ significantly depending on which of the two drugs is prescribed and why.
Conclusion
Ozempic’s list price is high enough that no patient should be paying it without first checking whether a manufacturer program applies to their situation. For most uninsured patients, NovoCare’s self-pay pricing is the realistic floor. For commercially insured patients with coverage already in place, the savings card can bring the cost down to near nothing. Medicare enrollees and low-income patients have separate paths worth exploring directly rather than assuming the highest advertised price is the only option.
Medical information disclaimer: This article is for general informational purposes only and is not medical or financial advice. Drug pricing, manufacturer programs, and insurance coverage change frequently; always confirm current terms directly with NovoCare, your insurance plan, or your pharmacist before making a treatment or payment decision. Consult your prescriber before starting, stopping, or switching any medication, including any compounded alternative.
